Mouse IFN-γ T cell ELISPOT kit - 5-plate

SKU
CT317-B5
Complete ELISPOT kit including all reagents (480 determinations).
Format
5-plate
Price
€ 670
Documentation
Data sheet
Manual
SDS
Reactivity
Mouse
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT kits provide a complete, ready-to-use solution for reliable, high-performance ELISPOT assay. Each kit includes all essential components: coating and detection antibodies, streptavidin-HRP, TMB substrate, blocking stock solution, dilution buffer, and Tween-20.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
15978
Related Products
CT317-B2 - Mouse IFN-γ T cell ELISPOT kit - 2-plate

References

Authors, et al. Title Journal Year Volume Pages
Michaël Lukens V Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node J Virol 2009 83 7235-43
Yanmin Wan Deglycosylation or partial removal of HIV-1 CN54 gp140 V1/V2 domain enhances env-specific T cells AIDS Res Hum Retroviruses 2009 25 607-17
I Zubkova T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation Vaccine 2009 27 2594-602
Wanhong Yao Enhanced immune response and protection efficacy of a DNA vaccine constructed by linkage of the Mycobacterium tuberculosis Ag85B-encoding gene with the BVP22-encoding gene J Med Microbiol 2009 58 462-468
Hui Hu Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model Vaccine 2009 27 1758-63
Pan Tao Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice Antiviral Res 2009 81 253-60
Quanjiao Chen Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus Virus Genes 2009 38 30-8
Jiu Wang Evaluation of a recombinant BCG expressing antigen Ag85B and PPE protein Rv3425 from DNA segment RD11 of Mycobacterium tuberculosis in C57BL/6 mice Med Microbiol Immunol 2009 198 5-11
Liyun Zheng A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice BMC Infect Dis 2009 9 17
Victoria Velazquez Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy Blood 2009 113 538-45